MC
TNDM icon

Menta Capital’s Tandem Diabetes Care TNDM Stock Holding History

Menta Capital’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$371K Buy
+5,744
New +$371K 0.16% 245

Other funds holding TNDM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Menta Capital's TNDM Position: Q2 2019 in Review

Menta Capital opened a new position in Tandem Diabetes Care (TNDM) in Q2 2019: 5,744 shares worth $371K. The stake represents 0.16% of the portfolio and ranks #245 among its holdings.

261 funds tracked by Wall St. Rank hold TNDM as of Q2 2019.

  • Menta Capital held 5,744 shares of Tandem Diabetes Care worth $371K as of Q2 2019.
  • Tandem Diabetes Care was a new Menta Capital position in Q2 2019.
  • Tandem Diabetes Care made up 0.16% of Menta Capital's portfolio in Q2 2019, its #245 holding.
  • 261 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2019.

Based on Menta Capital's 13F filing for Q2 2019, filed 7 Aug 2019.